Prefer a chat interface with context about you and your work?
Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach
The COVID-19 pandemic has increased the need for innovative quantitative decision tools to support rapid development of safe and efficacious vaccines against SARS-CoV-2. To meet that need, we developed and applied a model-based meta-analysis (MBMA) approach integrating non-clinical and clinical immunogenicity and protection data.